Transfer: Rohini challenges CAT order in HC

Bengaluru, July 23: The Janta Dal (Secular) and Congress that had joined hands together in Karnataka ‘to keep communal forces at bay, have once again turned archrivals. The development comes a year after the collapse of JD(S)-Congress coalition government in the state.

Recently, Leader of the Opposition Siddaramaiah claimed that the Congress would have won at least 10 seats in the Lok Sabha elections had it not been for the alliance with the JD(S). In response, former chief minister H D Kumaraswamy of the JD(S), who headed the coalition government, blamed the Congress for its many 'conspiracies'.

In a series of tweets on Wednesday, Kumaraswamy said he was prompted by Siddarmaiah's claims to recall what transpired during the coalition government. 

"There will never be a future alliance with Congress," Kumaraswamy declared, in a letter to his party colleagues on Wednesday. He claimed that there were many conspiracies on part of Congress, which led to the fall of the coalition government.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.